This meant an absolute risk reduction of 11% in the ECMO arm, but this did not reach statistical significance.
← all excerpts
EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?
1
—
—
This meant an absolute risk reduction of 11% in the ECMO arm, but this did not reach statistical significance.